The global syphilis treatment market is experiencing substantial growth due to growing incidences of the disease worldwide. This situation is driven by numerous factors, including lack of access to healthcare, risky sexual practices, and unsatisfactory public health interventions. The market comprises a wide range of treatments, with bacteriostatic